R v Secretary of State for Health, ex parte British American Tobacco and Imperial Tobacco Case C-491/01, [2002] ECR I-11453
Facts
British American Tobacco and Imperial Tobacco challenged the United Kingdom’s proposed implementation of Directive 2001/37. The directive revised common rules on tobacco manufacture, presentation and sale, including cigarette yields and package warnings. The manufacturers disputed its legal basis and raised objections involving proportionality, property and subsidiarity. The High Court referred questions about validity and interpretation to the European Court. Existing EU tobacco rules made the case particularly useful for testing whether the legislature could adopt stronger harmonisation measures when health concerns and market conditions had changed.
Legal Issue
Could the internal market legal basis support revised tobacco product rules where public health strongly influenced their content and earlier harmonising legislation already covered the sector?
Held
The Court found no ground in the questions examined for invalidating the directive. Article 95 EC, now Article 114 TFEU, could support measures genuinely improving the conditions for the internal market. Public health could be a decisive consideration within such harmonisation. Existing legislation did not freeze the regulatory scheme: the legislature could respond to changed circumstances, knowledge and perceptions of risk. The Court also rejected the relevant proportionality and subsidiarity objections. It treated the additional reference to Article 133 EC as a formal defect which did not invalidate the measure in the circumstances. The conclusion was tied to the directive’s design and objectives, rather than recognising a general EU power to regulate any activity on health grounds.
⭐ Legal Principle
Internal market harmonisation may pursue a high level of health protection and revise earlier harmonised rules where the measure genuinely addresses market conditions. Existing harmonisation does not prevent legislative adaptation, but a public health objective alone does not supply the missing Treaty competence.
Significance
British American Tobacco helps explain why a health-related EU measure can survive an internal market legal-basis challenge. The constitutional question is whether the measure genuinely addresses the relevant market objective, not whether health protection matters to the legislature. It belongs alongside the tobacco advertising judgments and Philip Morris. Its separate ruling on preliminary-reference admissibility also demonstrates how a manufacturer may challenge validity through genuine national proceedings before the directive has been transposed.
Common exam questions about this case
Does a strong health objective make Article 114 unavailable?
No. A measure may improve internal market conditions while also aiming for a high level of health protection. The Court accepted that health could decisively shape the content of harmonisation. The legal basis still requires a genuine market connection, so invoking health is not itself enough to establish competence.
Why did earlier tobacco harmonisation not prevent the new directive?
Harmonisation is capable of development. The legislature must be able to respond to changing circumstances and understanding of health risks rather than remain tied to an earlier regulatory settlement. The existence of previous rules therefore did not itself show that the revised measure exceeded EU competence.
What is the difference between competence and proportionality in this case?
Competence asks whether the Treaty authorises the EU to legislate on the relevant basis. Proportionality asks whether the chosen measures are justified in pursuing their objectives. A valid legal basis does not eliminate the proportionality inquiry, and a desirable health objective cannot cure a lack of competence.